Company Filing History:
Years Active: 2021
Title: Innovations of James B. Flanegan in Vaccine Development
Introduction
James B. Flanegan is an accomplished inventor based in Gainesville, FL (US). He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on enhancing the safety and efficacy of vaccines, particularly in relation to poliovirus.
Latest Patents
James B. Flanegan holds a patent for "N-antigenic form poliovirus virus-like particles comprising thermostable mutations." This patent describes compositions of virus-like particles (VLPs) of poliovirus that incorporate one or more stabilizing mutations. These mutations confer a higher degree of thermostability to the N-antigenic form of the VLPs. Importantly, these VLPs are non-infectious, making them safer for use in vaccine development and administration to clinical subjects. He has 1 patent to his name.
Career Highlights
Flanegan is associated with the University of Florida Research Foundation, Incorporated, where he continues to advance his research in vaccine technology. His work has the potential to significantly impact public health by improving vaccine formulations.
Collaborations
James B. Flanegan has collaborated with notable colleagues, including Robert McKenna and Christopher Daniel Boone. These collaborations have fostered a productive research environment, leading to innovative solutions in vaccine development.
Conclusion
James B. Flanegan's contributions to vaccine development through his patented innovations highlight the importance of research in enhancing public health safety. His work exemplifies the critical role of inventors in advancing medical science.